Pembrolizumab‐caused polyradiculoneuropathy as an immune‐related adverse event-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pembrolizumab‐caused polyradiculoneuropathy as an immune‐related adverse event

Published:2021-05-03 Issue:4 Volume:41 Page:266-272
ISSN:0919-6544
Container-title:Neuropathology
language:en
Short-container-title:Neuropathology

Author:

Kurashige Takashi¹^ORCID,Mito Mineyo²,Yamamoto Hideki³,Sugiura Tomohito¹,Onoe Takashi⁴,Kuraoka Kazuya⁴,Nakano Kikuo²,Torii Tsuyoshi¹

Affiliation:

1. Department of Neurology National Hospital Organization Kure Medical Center and Chugoku Cancer Center Kure, Hiroshima Japan

2. Department of Respiratory National Hospital Organization Kure Medical Center and Chugoku Cancer Center Kure, Hiroshima Japan

3. Department of Diagnostic Pathology National Hospital Organization Kure Medical Center and Chugoku Cancer Center Kure, Hiroshima Japan

4. Department of Surgery National Hospital Organization Kure Medical Center and Chugoku Cancer Center Kure, Hiroshima Japan

Funder

Tsuchiya Foundation

Publisher

Wiley

Subject

Clinical Neurology,General Medicine,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/neup.12729

Reference11 articles.

1. PD-1 Blockers

2. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

3. Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab

4. Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy

5. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates in the therapeutic uses of Pembrolizumab: a brief narrative review;Clinical and Translational Oncology;2024-04-24

2. Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer;Frontiers in Immunology;2023-01-27

3. Research progress on mechanisms and predictive biomarkers for immune-related adverse events;2023-01-25

4. Cisplatin/etoposide/pembrolizumab;Reactions Weekly;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3